Matt Coelho

Matt Coelho

mattcoelho.bsky.social

Cancer Research UK Career Development Fellow at the Wellcome Sanger Institute - gene editing - drug resistance - cancer

👤 Joined on 15 November 2024

166

Followers

117

Following

30

Total Posts

📜 Kullanıcı Geçmişi

  • 15 Kas 2024, 18:16
    🎉 Bluesky'e katıldı - İlk kullanıcı adı: @mattcoelho.bsky.social

🚫 Blokladığı Kullanıcılar

❤️ Beğendiği Gönderiler

1st genome sequenced (Sanger 1977), 1st genome synthesised (Venter 2003), 1st genome + proteome fully mutated (Huijin Xiangua 2026!) @crg.eu @sangerinstitute.bsky.social Complete Mutagenesis of the Genome and Proteome of ΦX174 www.biorxiv.org/content/10.6...

Show Post

Excited to share our latest work in Nature. Applying single-molecule and single-cell DNA sequencing methods, we uncover an extraordinary landscape of somatic mutations in immune checkpoint genes in autoimmune B cells, suggesting that somatic mutations may be key to autoimmunity [1/n] rdcu.be/fdqbr

Show Post

Opening the second day of talks at MSS 2026 is Prof. Matthew Hurles of the Wellcome Sanger Institute. His talk, 'Scaling MAVEs: Is this the end of the beginning?' discusses progress in efforts to deliver MAVEs at scale. #VariantEffect26 #MAVEs #AtlasOfVariantEffectsAlliance

Show Post

Our final speaker before morning coffee is Doug Fowler from the University of Washington. His talk details pathway-scale variant effect mapping in human cells with LABEL-seq. #VariantEffect26 #LABELseq ##DeepMutationalScanning #AtlasOfVariantEffectsAlliance

Show Post

Now, Vanessa Burns from the Wellcome Sanger Institute takes the stage to speak about saturation genome editing (SGE) to clarify variant effects within 5' UTRs of neurodevelopmental disorder (NDD) genes. #VariantEffect26 #SGE #NDD #AtlasOfVariantEffectsAlliance

Show Post

Select language

Install App

Install App